In a 17‑year‑old female with ferritin 18 µg/L, hemoglobin 11.8 g/dL, hematocrit 35.2 %, MCV 80 fL, MCH 26.9 pg, RDW 14.3 %, and CRP 15.6 mg/L, what is the most likely diagnosis and appropriate initial management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Deficiency Anemia in an Adolescent Female

This 17-year-old female has iron deficiency anemia (IDA) and should be started on oral iron supplementation with concurrent evaluation for underlying causes of iron loss, particularly menstrual blood loss and dietary insufficiency.

Diagnosis

The laboratory findings definitively indicate iron deficiency anemia:

  • Ferritin 18 µg/L is below the physiologically-based threshold of approximately 20-25 µg/L for adolescent females, indicating depleted iron stores 1. While traditional WHO thresholds use <15 µg/L for women, recent physiologically-based evidence using hemoglobin and soluble transferrin receptor identified optimal thresholds of 20 µg/L for children and 25 µg/L for non-pregnant women 1.

  • Hemoglobin 11.8 g/dL represents anemia in this age group, combined with microcytosis (MCV 80.2 fL) and hypochromia (MCH 26.9 pg), which are classic findings in IDA 2, 3.

  • The elevated CRP (15.6 mg/L) indicates concurrent inflammation, which is an important caveat. However, the ferritin remains well below 45-100 µg/L, the range where inflammation typically masks iron deficiency 4. In this case, the low ferritin reliably indicates true iron depletion despite inflammation.

  • RDW 14.3% is at the upper limit of normal, which has 94% sensitivity for iron deficiency and supports the diagnosis 5.

Initial Management Algorithm

Step 1: Iron Supplementation

  • Initiate oral iron therapy immediately as first-line treatment 4. Standard dosing is elemental iron 100-200 mg daily, though lower doses may improve tolerability.
  • Common side effects include nausea, abdominal pain, and constipation, which frequently limit adherence 4.
  • Consider intravenous iron if oral iron is not tolerated or ineffective after 4-6 weeks 4.

Step 2: Identify the Source of Iron Loss

The diagnostic workup should focus on:

  • Menstrual history: Heavy menstrual bleeding is the most common cause in adolescent females. Quantify menstrual blood loss and duration 4.

  • Dietary assessment: Evaluate iron intake, particularly in vegetarians or those with restrictive eating patterns 4.

  • Gastrointestinal evaluation: While less common in this age group without GI symptoms, consider screening for celiac disease and H. pylori if other causes are not identified 4.

Step 3: Address the Inflammation

  • Investigate the source of elevated CRP (15.6 mg/L), as chronic inflammation can impair iron absorption and utilization.
  • Common causes in adolescents include infections, autoimmune conditions, or inflammatory bowel disease.

Important Clinical Pitfalls

Anemia-based screening alone has only 15.6-18.8% sensitivity for detecting iron deficiency in adolescent females 6. This patient's hemoglobin of 11.8 g/dL might not trigger concern in routine screening, yet she has significant iron depletion. Among female adolescents aged 16-18, the rate of absent iron stores is 15.9% and iron-deficient erythropoiesis affects 50.6% 7.

The presence of inflammation (elevated CRP) does not exclude iron deficiency in this case. When ferritin is <45 µg/L with inflammation, iron deficiency is still highly likely 4. Confirmatory testing with transferrin saturation or soluble transferrin receptor would only be needed if ferritin were 45-100 µg/L 4.

Monitoring Response

  • Recheck hemoglobin and ferritin after 8-12 weeks of iron therapy to assess response.
  • Target ferritin >30 µg/L and normalization of hemoglobin for adequate repletion.
  • If no response occurs, consider IV iron or investigate malabsorption disorders 4.

Related Questions

What could cause low HGB, MCV, MCH, ferritin, and potassium, along with high RDW, ESR, glucose, and creatinine, and bladder and stomach lining thickening?
What does a ferritin level of 11 indicate in a 16-year-old female?
What is the diagnosis and treatment for an 18-year-old female with episodes of lightheadedness, low hemoglobin, low Mean Corpuscular Volume (MCV), low Mean Corpuscular Hemoglobin (MCH), low Mean Corpuscular Hemoglobin Concentration (MCHC), and high Red Cell Distribution Width (RDW)?
What is the ideal ferritin level for a 15-year-old female with a current ferritin level of 10 ng/mL?
What is the next step in managing a patient with a low MCHC and elevated RDW?
In a 62‑year‑old patient, are retinal emboli equivalent to a retinal stroke (acute retinal artery occlusion)?
Should Neisseria gonorrhoeae be treated empirically when the gonorrhea screening test is negative but Chlamydia trachomatis test is positive?
What is the optimal interval between the intravenous bolus of regadenoson (0.4 mg) and administration of the radiopharmaceutical during a pharmacologic stress test?
What are the recommended treatments for hot flashes in perimenopausal women?
What is the recommended management for a patient with retrosternal and epigastric burning sensations and a normal endoscopy showing no severe gastritis or gastroesophageal reflux disease (GERD) changes?
What PO (per os) antibiotic regimen should be used to cover MRSA (methicillin‑resistant Staphylococcus aureus), gram‑negative rods, and anaerobes while avoiding vancomycin and daptomycin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.